FindTrial
Sign In

TAVI and intraoperative hemodynamic collapse

Clinical study of transcatheter aortic valve implantation for the treatment of aortic valve disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043158
Enrollment
Unknown
Registered
2021-02-07
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve disease

Interventions

case series:Nil

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients received transcatheter aortic valve implantation.

Exclusion criteria

Exclusion criteria: Patients with predominant aortic regurgitation; patients undergoing valve-in-valve surgery with surgical biologic fracture.

Design outcomes

Primary

MeasureTime frame
in-hospital death;rate of CPB implantation;Length of hospital stay;Mean postoperative gradient;—

Countries

China

Contacts

Public ContactJiang Nan

Tianjin Chest Hospital

jiangnantj@126.com+86 18002093500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026